Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever Virus. [PDF]
Lotonin K +21 more
europepmc +1 more source
Development of a scalable production bioprocess for HIV-1 virus-like particles coupling continuous VLP harvesting with end-to-end downstream processing. [PDF]
Lorenzo E +5 more
europepmc +1 more source
Immunogenicity and protective efficacy of MERS CoV, NL140422, and HKU4 spike protein nanoparticle vaccines. [PDF]
Halfmann PJ +5 more
europepmc +1 more source
Inhibitory Effect of <i>Curcuma xanthorrhiza</i> Extract Against SARS-CoV-2 D614G Virus-Like Particle (VLP): Implications for COVID-19 Therapy Development. [PDF]
Mushlih M +13 more
europepmc +1 more source
Research Progress Towards Poliovirus Virus-like Particle Vaccines: A Review. [PDF]
Han T +5 more
europepmc +1 more source
4.4 Generate VLPs expressing Pfs25 alone, Pfs48/45 alone and bivalent VLPs
Generate VLPs expressing Pfs25 alone, Pfs48/45 alone and bivalent ...
openaire +1 more source
Differential Clinical Signatures of Vulvar Lichen Sclerosus, Lichen Planus, and Chronic Lichen Simplex: A Comparative Study in 1355 Patients. [PDF]
Hu Q +8 more
europepmc +1 more source
High-Precision Indoor VLP Scheme Based on the Synergy of SMO Multipath Suppression and Intelligent Algorithms. [PDF]
Yang Y, Zhang J, Liu S.
europepmc +1 more source

